Our data showed that the loss of Lkb1 (even in haploinsufficiency) allowed the development of BrafV600E‐mutant melanomas with a low incidence (11.1–31.2%) 10 months after BrafV600E activation and Lkb1 knockout, most likely due to an increase in genomic instability. Here, STK11 is linked to melanoma.